Assessment of cerebrovascular reactivity during major depression and after remission of disease

Annals of Indian Academy of Neurology

Volumn 13, Issue 1, 2010, Pages 52-56

  Vakilian, Alireza ^a   Iranmanesh, Farhad ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cerebrovascular reactivity; Depression; Transcranial Doppler ultrasound

Indexed keywords

ADULT; APNEA; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BREATH HOLDING; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; REMISSION;

EID: 77950480107     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.61278     Document Type: Article

References (18)

1. Larson SL, Owens PL, Ford D, Eaton W. Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke 2001;32:1979-1983 (Pubitemid 32878509)
2. Ohira T, Iso H, Satoh S, Sankai T, Tanigawa T, Ogawa Y, et al. Prospective study of depressive symptoms and risk of stroke among japanese. Stroke 2001;32:903-908 (Pubitemid 32285158)
3. Everson SA, Roberts RE, Goldberg DE, Kaplan GA. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med 1998;158:1133-1138
4. Simonsick EM, Wallace RB, Blazer DG, Berkman LF. Depressive symptomatology and hypertension-associated morbidity and mortality in older adults. Psychosom Med 1995;57:427-435
5. JonSymptoms of depression as a prospective risk factor for stroke. Psychosom Med 2000;62:463-471 (Pubitemid 30604788)
6. Rabi-Ziki? T, Zarkov M, Nedi? A, Slankamenac P, Zivanovi? Z, Dobrenov D. Depression as the cause and consequence of cerebrovascular diseases. Med Pregl 2007;60:255-260
7. Schwertfeger N, Neu P, Schlattmann P, Lemke H, Heuser I, Bajbouj M. Cerebrovascular reactivity over time course in healthy subjects. J Neurol Sci 2006;249:135-139 (Pubitemid 44679703)
8. Fülesdi B, Limburg M, Bereczki D, Michels RP, Neuwirth G, Legemate D, Valikovics A, et al. Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes 1997;46:1840-1845 (Pubitemid 27456419)
9. Troisi E, Attanasio A, Matteis M, Bragoni M, Monaldo BC, Caltagirone C, et al. Cerebral hemodynamics in young hypertensive subjects and effects of atenolol treatment. J Neurol Sci 1998;159:115-119 (Pubitemid 28365893)
10. Yonas H, Smith HA, Durham SR, Pentheny SL, Johnson DW. Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg 1993;79:483-489 (Pubitemid 23289802)
11. Silvestrini M, Troisi E, Matteis M, Cupini LM, Caltagirone C. Transcranial Doppler assessment of cerebrovascular reactivity in symptomatic and asymptomatic severe carotid stenosis. Stroke 1996;27:1970-1973 (Pubitemid 26372565)
12. Molina C, Sabín JA, Montaner J, Rovira A, Abilleira S, Codina A. Impaired cerebrovascular reactivity as a risk marker for first-ever lacunar infarction: A case-control study. Stroke 1999;30:2296-2301 (Pubitemid 29517725)
13. Neu P, Schlattmann P, Schilling A, Hartmann A. Cerebrovascular reactivity in major depression: a pilot study. Psychosom Med 2004;66:6-8. (Pubitemid 38146526)
14. First MB, Spitzer RL, Gibbon M, Williams JBW, Caltagirone C. Structural Clinical interview for DSM-IV Axis I Disorders (SCID I):Administration Booklet. Washington DC, American Press, 1997.
15. Hamilton M. Rating depressive patients. J Clin Psychiatry 1980;41:21-24 (Pubitemid 11203735)
16. Morioka C, Kondo H, Akashi K, Matsumura K, Ochi N, Makinaga G, The continuous and simultaneous blood flow velocity measurement of four cerebral vessels and a peripheral vessel during cigarette smoking. Psychopharmacology (Berl) 1997;131:220-229 (Pubitemid 27283583)
17. de Castro AG, Bajbouj M, Schlattmann P, Lemke H, Heuser I, Neu P. Cerebrovascular reactivity in depressed patients without vascular risk factors. J Psychiatr Res 2008;42:78-82. (Pubitemid 47566424)
18. Ungvari Z, Pacher P, Kecskeméti V, Koller A. Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca(2+) channel opener. Stroke 1999;30:1949-1954. (Pubitemid 29411840)